Large cell carcinoma of lung: On the verge of extinction?

Seminars in Diagnostic Pathology

Volumn 31, Issue 4, 2014, Pages 278-288

  Weissferdt, Annikka ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Classification; Large cell carcinoma; Lung; Non small cell lung cancer

Indexed keywords

ACINAR CELL CARCINOMA; ANAPLASTIC CARCINOMA; ARTICLE; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CLEAR CELL CARCINOMA; EPIDERMOID TUMOR; GIANT CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; KERATINIZATION; LARGE CELL CARCINOMA; LARGE CELL LUNG CARCINOMA; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CARCINOMA; LYMPHOEPITHELIOMA; NON SMALL CELL LUNG CANCER; PAPILLARY CARCINOMA; RHABDOID TUMOR; SMALL CELL CARCINOMA; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL; UNDIFFERENTIATED CARCINOMA; LUNG; LUNG TUMOR; NOMENCLATURE; PATHOLOGY;

CARCINOMA, LARGE CELL; HUMANS; LUNG; LUNG NEOPLASMS; TERMINOLOGY AS TOPIC;

EID: 84922281762     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2014.06.005     Document Type: Article

References (66)

1. WHO Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart 2004, IARC Press, Lyon, France. W.D. Travis, E. Brambilla, H.K. Müller-Hermelink, C.C. Harris (Eds.).
2. SEER Cancer Statistics Review 1975-2009 2011, National Cancer Institute, National Cancer Institute, Bethesda, MD.
3. Yamagata N., Shyr Y., Yanagisawa K., et al. A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin Cancer Res 2003, 9(13):4695-4704.
4. Hou J., Aerts J., den Hamer B., et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 2010, 5(4):e10312.
5. Takeuchi T., Tomida S., Yatabe Y., et al. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol 2006, 24(11):1679. -88.3.
6. Pardo J., Martinez-Peñuela A.M., Sola J.J., et al. Large cell carcinoma of the lung: an endangered species?. Appl Immunohistochem Mol Morphol 2009, 17(5):383-392.
7. Rekhtman N., Tafe L.J., Chaft J.E., et al. Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Mod Pathol 2013, 26(4):511-522.
8. Barbareschi M., Cantaloni C., Del Vescovo V., et al. Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis. Am J Clin Pathol 2011, 136(5):773-782.
9. Hwang D.H., Szeto D.P., Perry A.S., et al. Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma. Arch Pathol Lab Med 2014, 138(5):626-635.
10. Rossi G., Mengoli M.C., Cavazza A., et al. Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology. Virchows Arch 2014, 464(1):61-68.
11. NCCN Guidelines. Non-small cell lung cancer, version 2.2013. Available at: http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.
12. Liebow A.A. Tumors of the Lower Respiratory Tract. Atlas of Tumor Pathology 1952, Armed Forces Institute of Pathology, Washington, DC.
13. Kreyberg L. Main histological types of primary epithelial lung tumours. Br J Cancer 1961, 15:206-210.
14. Histological Typing of Lung Tumours 1967, World Health Organization, Geneva. 1st ed. L. Kreyberg, A.A. Liebow, E.A. Uehlinger (Eds.).
15. Histological Typing of Lung Tumours 1981, World Health Organization, Geneva. 2nd ed. (Eds.).
16. WHO Histological Classification of Tumours: Histological Typing of Lung and Pleural Tumours 1999, Springer Verlag, Berlin. 3rd ed. W.D. Travis, T.V. Colby, B. Corrin (Eds.).
17. Kodama T., Shimosato Y., Koide T., et al. Large cell carcinoma of the lung-ultrastructural and immunohistochemical studies. Jpn J Clin Oncol 1985, 15(2):431-441.
18. Travis W.D., Linnoila R.I., Tsokos M.G., et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991, 15(6):529-553.
19. Iyoda A., Hiroshima K., Toyozaki T., et al. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer 2001, 91(11):1992-2000.
20. Brambilla E., Moro D., Veale D., et al. Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol 1992, 23(9):993-1003.
21. Bégin L.R., Eskandari J., Joncas J., et al. Epstein-Barr virus related lymphoepithelioma-like carcinoma of lung. J Surg Oncol 1987, 36(4):280-283.
22. Han A.J., Xiong M., Gu Y.Y., et al. Lymphoepithelioma-like carcinoma of the lung with a better prognosis. A clinicopathologic study of 32 cases. Am J Clin Pathol 2001, 115(6):841-850.
23. Yamamato T., Yazawa T., Ogata T., et al. Clear cell carcinoma of the lung: a case report and review of the literature. Lung Cancer 1993, 10(1-2):101-106.
24. Yousem S.A. Immunohistochemical and molecular characterization of clear cell carcinoma of the lung. Hum Pathol 2013, 44(11):2467-2474.
25. Cavazza A., Colby T.V., Tsokos M., et al. Lung tumors with a rhabdoid phenotype. Am J Clin Pathol 1996, 105(2):182-188.
26. Izquierdo-Garcia F.M., Moreno-Mata N., Herranz-Aladro M.L., et al. Lung carcinoma with rhabdoid component. A series of seven cases associated with uncommon types of non-small cell lung carcinomas and alveolar entrapment. Histol Histopathol 2010, 25(10):1287-1295.
27. Travis W.D., Rush W., Flieder D.B., et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998, 22(8):934-944.
28. Brambilla E., Travis W.D., Colby T.V., et al. The new World Health Organization classification of lung tumours. Eur Respir J 2001, 18(6):1059-1068.
29. Rusch V.W., Klimstra D.S., Venkatraman E.S. Molecular markers help characterize neuroendocrine lung tumors. Ann Thorac Surg 1996, 62(3):798-809.
30. Peng W.X., Sano T., Oyama T., et al. Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma. Lung Cancer 2005, 47(2):225-233.
31. Przygodzki R.M., Finkelstein S.D., Langer J.C., et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol 1996, 148(5):1531-1541.
32. Wick M.R., Berg L.C., Hertz M.I. Large cell carcinoma of the lung with neuroendocrine differentiation. A comparison with large cell "undifferentiated" pulmonary tumors. Am J Clin Pathol 1992, 97(6):796-805.
33. Harada M., Yokose T., Yoshida J., et al. Immunohistochemical neuroendocrine differentiation is an independent prognostic factor in surgically resected large cell carcinoma of the lung. Lung Cancer 2002, 38(2):177-184.
34. Ionescu D.N., Treaba D., Gilks C.B., et al. Non-small cell lung carcinoma with neuroendocrine differentiation-an entity of no clinical or prognostic significance. Am J Surg Pathol 2007, 31(1):26-32.
35. Schleusener J.T., Tazelaar H.D., Jung S.H., et al. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma. Cancer 1996, 77(7):1284-1291.
36. Linnoila R.I., Piantadosi S., Ruckdeschel J.C. Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience. Chest 1994, 106(Suppl 6):367S-371S.
37. Carles J., Rosell R., Ariza A., et al. Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer. Lung Cancer 1993, 10(3-4):209-219.
38. Moro D., Brichon P.Y., Brambilla E., et al. Basaloid bronchial carcinoma. A histologic group with a poor prognosis. Cancer 1994, 73(11):2734-2739.
39. Moro-Sibilot D., Lantuejoul S., Diab S., et al. Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis. Eur Respir J 2008, 31(4):854-859.
40. Kim D.J., Kim K.D., Shin D.H., et al. Basaloid carcinoma of the lung: a really dismal histologic variant?. Ann Thorac Surg 2003, 76(6):1833-1837.
41. Marci V., Volante M., Cappia S., et al. Basaloid adenocarcinoma. A new variant of pulmonary adenocarcinoma. Virchows Arch 2007, 451(3):729-736.
42. Chan J.K., Hui P.K., Tsang W.Y., et al. Primary lymphoepithelioma-like carcinoma of the lung. A clinicopathologic study of 11 cases. Cancer 1995, 76(3):413-422.
43. Chang Y.L., Wu C.T., Shih J.Y., et al. New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas. Am J Surg Pathol 2002, 26(6):715-723.
44. Ho J.C., Wong M.P., Lam W.K. Lymphoepithelioma-like carcinoma of the lung. Respirology 2006, 11(5):539-545.
45. Castro C.Y., Ostrowski M.L., Barrios R., et al. Relationship between Epstein-Barr virus and lymphoepithelioma-like carcinoma of the lung: a clinicopathologic study of 6 cases and review of the literature. Hum Pathol 2001, 32(8):863-872.
46. Morgan A.D., Mackenzie D.H. Clear-cell carcinoma of the lung. J Pathol Bacteriol 1964, 87:25-27.
47. Katzenstein A.L., Prioleau P.G., Askin F.B. The histologic spectrum and significance of clear-cell change in lung carcinoma. Cancer 1980, 45(5):943-947.
48. Falconieri G., Moran C.A., Pizzolitto S., et al. Intrathoracic rhabdoid carcinoma: a clinicopathological, immunohistochemical, and ultrastructural study of 6 cases. Ann Diagn Pathol 2005, 9(5):279-283.
49. Tamboli P., Toprani T.H., Amin M.B., et al. Carcinoma of lung with rhabdoid features. Hum Pathol 2004, 35(1):8-13.
50. Chetty R. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells. Pathology 2000, 32(3):209-212.
51. Dettmer M., Hench J., Pang B., et al. Rhabdoid large cell carcinoma of lung, with illustrative immunohistochemical and molecular findings. Appl Immunohistochem Mol Morphol 2012, 20(3):208-213.
52. Yesner R. Large cell carcinoma of the lung. Semin Diagn Pathol 1985, 2(4):255-269.
53. Rossi A., Maione P., Bareschino M.A., et al. The emerging role of histology in the choice of first-line treatment of advanced non-small cell lung cancer: implication in the clinical decision-making. Curr Med Chem 2010, 17(11):1030-1038.
54. Langer C.J. Individualized therapy for patients with non-small cell lung cancer: emerging trends and challenges. Crit Rev Oncol Hematol 2012, 83(1):130-144.
55. Johnson D.H., Fehrenbacher L., Novotny W.F., et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2004, 22(11):2184-2191.
56. Rosell R., Carcereny E., Gervais R., et al. Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 2012, 13(3):239-246.
57. Sasaki T., Jänne P.A. New strategies for treatment of ALK-rearranged non-small cell lung cancers. Clin Cancer Res 2011, 17(23):7213-7218.
58. Scagliotti G., Hanna N., Fossella F., et al. The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies. Oncologist 2009, 14(3):253-263.
59. Albain K.S., True L.D., Golomb H.M., et al. Large cell carcinoma of the lung. Ultrastructural differentiation and clinicopathologic correlations. Cancer 1985, 56(7):1618-1623.
60. Delmonte V.C., Alberti O., Saldiva P.H. Large cell carcinoma of the lung. Ultrastructural and immunohistochemical features. Chest 1986, 90(4):524-527.
61. Downey R.J., Asakura S., Deschamps C., et al. Large cell carcinoma of the lung: results of resection for a cure. J Thorac Cardiovasc Surg 1999, 117(3):599-604.
62. Uzaslan E., Ebsen M., Stuempel T., et al. Surfactant protein A detection in large cell carcinoma of the lung. Appl Immunohistochem Mol Morphol 2006, 14(1):88-90.
63. Monica V., Ceppi P., Righi L., et al. Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung. Mod Pathol 2009, 22(5):709-717.
64. Mukhopadhyay S., Katzenstein A.L. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol 2011, 35(1):15-25.
65. Rosell R., Moran T., Queralt C., et al. Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009, 361(10):958-967.
66. Travis W.D., Brambilla E., Noguchi M., et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med 2013, 137(5):668-684.